ki:elements

CAADMI – Study on Cerebral Amyloid Angiopathy and Alzheimer’s disease

The aim of the study is to identify clinical markers of vascular amyloid deposition in patients with Alzheimer’s disease, focusing on cognitive abilities and MRI features such as vascular reactivity.

Share this article

Discover more articles

Validation ki:e SB-C

We are grateful to announce that we will soon be collaborating in a major new decentralized trial, funded by the Alzheimer Drug Discoveries Foundation (ADDF)

Read

ki:e SB-C

Today, clinical research on early Alzheimer’s Disease (AD) dementia relies on invasive procedures and extended cognitive examinations both for screening and within trial usage. With

Read

Listen to Alzheimer

Alzheimer’s disease (AD) affects speech and language (Cummings, Benson, Hill & Read, 1985). This can be caused by the disease affecting language as a neurocognitive

Read